MedPath
NMPA Approval

Osilodrostat Phosphate Tablets

国药准字HJ20240101

September 19, 2024

Drug Information

磷酸奥唑司他片

适锐飒

片剂

1 mg (按C₁₃H₁₀FN₃计)

化学药品

September 19, 2024

September 18, 2029

Company Information

Applicant Company

Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92800 Puteaux, France

Manufacturing Company

Units 23-24, Tafarnaubach, Industrial Estate, Tafarnaubach,Tredegar, NP22 3AA, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥唑司他片 - NMPA 批准文号 | MedPath